Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma

BJU International

Volumn 104, Issue 6, 2009, Pages 790-794

  Soga, Norihito ^a,b   Yamakado, Koichiro ^b   Gohara, Hideo ^c   Takaki, Haruyuki ^b   Hiraki, Takao ^c   Yamada, Tomomi ^b   Arima, Kiminobu ^b   Takeda, Kan ^b   Kanazawa, Susumu ^c   Sugimura, Yoshiki ^b  

^a Mie University Graduate School of Medicine ^*  (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Lung metastasis; Percutaneous radiofrequency ablation; Renal cell carcinoma

Indexed keywords

CEFAZOLIN;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; CANCER PALLIATIVE THERAPY; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; TUBE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, RENAL CELL; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 69249140675     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08459.x     Document Type: Article

References (20)

1. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005 48 : 77 81
2. Swanson DA. Surgery for metastases of renal cell carcinoma. Scand J Surg 2004 93 : 150 155
3. Weiss L, Harlos JP, Torhorst J et al. Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 1988 114 : 605 612
4. Assouad J, Petkova B, Berna P, Dujon A, Foucault C, Riquet M. Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors. Ann Thorac Surg 2007 84 : 1114 1120
5. Friedel G, Hurtgen M, Penzenstadler M, Kyriss T, Toomes H. Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 1999 19 : 1593 1596
6. Yamakado K, Nakatsuka A, Kobayashi S et al. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol 2006 29 : 389 394
7. Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 2007 14 : 585 590
8. Steinke K, Habicht JM, Thomsen S, Soler M, Jacob AL. CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol 2002 25 : 543 546
9. Yan TD, King J, Sjarif A et al. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 2007 14 : 1718 1726 (Pubitemid 46790987)
10. Yamakado K, Hase S, Matsuoka T et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007 18 : 393 398
11. Lencioni R, Crocetti L, Cioni R et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008 9 : 621 628
12. Zagoria RJ, Chen MY, Kavanagh PV, Torti FM. Radio frequency ablation of lung metastases from renal cell carcinoma. J Urol 2001 166 : 1827 1828
13. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 5 : 649 655
14. Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005 235 : 728 739
15. Friedel G, Pastorino U, Buyse M et al. Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases - the International Registry of Lung Metastases. Zentralbl Chir 1999 124 : 96 103
16. Akeboshi M, Yamakado K, Nakatsuka A et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004 15 : 463 470
17. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998 16 : 2261 2266 (Pubitemid 28265066)
18. den Brok MH, Sutmuller RP, van der Voort R et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 2004 64 : 4024 4029
19. Napoletano C, Taurino F, Biffoni M et al. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol 2008 32 : 481 490
20. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006 13 : 1529 1537 (Pubitemid 44749666)